JPRN-UMIN000011598已完成未知
Independent clinical study: Researching drug-drug interaction between aliskiren and sitagliptin - Independent clinical study
The University of Tokyo Hospital Unit for Early and Exploratory Clinical Development0 个研究点目标入组 12 人开始时间: 2013年8月29日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 12
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 35years-old（—）
- 性别
- Male
入选标准
- 未提供
排除标准
- •a) Had medical history of participation in other clinical trials or the clinical study accompanied by medicine medication within three months. b) Has hypotension (blood pressure of less than 100 mmHg during systole), hypertension (blood pressure of 140 mmHg or higher during systole) or diabetes (HbA1c NGSP 6.5% or higher). c) Has donated or lost over 200 ml (1 unit) of blood within four weeks prior to study drug administration or 400 ml (2 units) within 3 months, or is anemic (less than Hb 12 g/dl). d) Has a serious neurological, cerebrovascular, hepatic, renal, endocrine, cardiovascular, digestive tract (including digestive tract disorders thought to impact trial drug absorption), respiratory, or metabolic disease in their medical history or as a concomitant condition. e) A clinically serious abnormality has been found by the principal investigator or one of the subinvestigators in the clinical test values, ECG or physical examination. f) Had a clinically serious illness within 30 days prior to study drug administration. g) Has used some sort of health food, or medical product within seven days prior to study drug administration or will use it during the study period. h) Has smoked tobacco, or ingested nicotine or alcohol within 30 days prior to study drug administration and, moreover, cannot abide by the prohibition on smoking and drinking during the study period. i) Tested positive for a specific abused substance (including alcohol) in the urine drug test at the screening. j) Anything else that the principal investigator or one of the subinvestigators considers to be disqualifying.
研究者
相似试验
已完成
不适用
Independent study: Researching drug-drug interaction bitween etizolam and itraconazoleeurosis, somnipathyJPRN-UMIN000011279P-One Clinic, Keikokai Medical Corp16
进行中（未招募）
4 期
A study comparing two suture materials for graft preparation in knee ligament surgeryCTRI/2021/09/036704Healthium Medtech Limited
已完成
4 期
A study comparing use of two surgical steel suture materials for closure of breastbone after cardiac surgeryCTRI/2020/10/028240Healthium Medtech Pvt Ltd72
已完成
4 期
Clinical equivalence study of two brands of polyester sutures (Trubond® and Ethibond) for fixation of the valvular prosthesis, in subjects undergoing aortic or mitral valve replacementCTRI/2020/04/024608Healthium Medtech Pvt Ltd formerly Sutures India Pvt Ltd88
已完成
不适用
A phase 1, open-label study to Investigate Drug-Drug Interaction (DDI) potential of Nipocalimab with coadministration of Etanercept or Hydroxychloroquine in healthy participants.NL-OMON49934Janssen-Cilag48